iifl-logo

Astrazeneca Pharma India Ltd Historical Data

10,057
(2.73%)
Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Astrazeneca Pharma India Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

7,970.5

8,2747,8008,119.513,58324,61,21,09411,011

13-May-2025

8,119.5

8,3198,070.58,189.54,0037,49,04,661.53,217

14-May-2025

8,190

8,289.58,0158,036.55,47514,49,72,021.58,157

15-May-2025

8,002.5

8,0937,9337,954.53,4479,18,05,423.55,499

16-May-2025

7,975

8,072.57,8177,837.55,47812,33,67,2728,347

19-May-2025

7,837.5

8,0577,8007,981.55,71512,71,61,669.56,572

20-May-2025

8,060

8,0607,8607,9234,0448,56,87,726.54,788

21-May-2025

7,923

8,1107,8987,940.56,20418,64,84,76613,618

22-May-2025

7,940.5

8,055.57,8808,0023,5687,71,60,893.54,986

23-May-2025

8,059

8,1057,922.57,959.52,8736,29,31,429.53,905

26-May-2025

7,999

8,108.57,943.58,006.56,11310,76,52,168.57,908

27-May-2025

8,063

8,1267,8747,905.54,0929,67,94,632.55,018

28-May-2025

7,967.5

7,967.57,8207,884.52,7746,53,91,9614,190

29-May-2025

7,885

7,963.57,8207,918.53,7488,89,61,3394,655

30-May-2025

7,820

8,0907,8207,9724,74412,20,10,204.55,831

02-Jun-2025

8,409

9,4888,400.59,336.51,70,66612,87,66,72,37882,493

03-Jun-2025

9,313

9,4109,0419,336.557,3232,85,24,50,64928,785

04-Jun-2025

9,250

10,0339,2509,493.51,19,5365,98,07,95,726.544,217

05-Jun-2025

9,495

9,9559,3629,88450,0552,61,70,46,223.536,490

06-Jun-2025

9,850

10,0509,5709,79026,6721,20,38,50,15114,957

09-Jun-2025

9,900

10,1309,75010,05720,78388,84,84,008.514,283

Astrazeneca Phar: Related NEWS

Top Stocks for Today - 10th June 2025
10 Jun 2025|06:43 AM

Here are some of the stocks that may see significant price movement today: ITD Cementation, Premier Energies, AstraZeneca, etc.

Read More
AstraZeneca Wins CDSCO Nod for Durvalumab in LS-SCLC
8 Mar 2025|11:42 PM

The approval is for two dosing forms: 120 mg/2.4 ml and 500 mg/10 ml.

Read More
AstraZeneca Secures CDSCO Approval for Lokelma in India
7 Mar 2025|11:00 AM

The company may import the powder form of sodium zirconium cyclosilicate for preparation of oral suspension as Lokelma in 5 g and 10 g formulation.

Read More
AstraZeneca India may sell North Bengaluru unit for ₹3,200 Crore
11 Feb 2025|11:56 AM

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land deal.

Read More
AstraZeneca Pharma India Gets CDSCO Nod for Lynparza Cancer Drug
26 Nov 2024|11:42 PM

It is used with Durvalumab to treat advanced or recurrent endometrial cancer in patients whose disease has not progressed after first-line treatment.

Read More
AstraZeneca to introduce COPD inhaler Breztri Aerosphere in India
19 Nov 2024|09:50 AM

This combination drug is used to treat chronic obstructive pulmonary disease (COPD) in adults, relieving symptoms and preventing exacerbations.

Read More
AstraZeneca India Posts 31% Revenue Surge in Q2
14 Nov 2024|10:48 AM

For the first half (H1) of FY25, the revenue rose to ₹795.5 Crore, driven by growth in oncology, biopharmaceuticals, and rare disease segments.

Read More
AstraZeneca Pharma Surges on CDSO Approval for Durvalumab in India
24 Sep 2024|06:20 PM

The company plans to launch Durvalumab in 120 mg/2.4 mL and 500 mg/10 mL solutions in India, pending statutory approvals.

Read More
AstraZeneca Pharma gets approval to launch cancer drug in India
24 Sep 2024|10:54 AM

The said indication is for the use of durvalumab in combination with chemotherapy as a neoadjuvant treatment.

Read More
Top 10 stocks for today - 24th September 2024
24 Sep 2024|09:00 AM

Here are some of the stocks that may see significant price movement today: Punjab National Bank, NTPC, Power Grid, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.